Modalities
mRNA Therapeutics and Vaccines
mRNA technologies are changing how vaccines and therapeutics are developed, manufactured, and scaled. Their speed, adaptability and modular design are creating new possibilities across infectious disease, oncology, rare disease, and personalized medicine.
Supporting the Next Generation of mRNA Therapeutics and Vaccines
Successful mRNA manufacturing depends on more than the molecule itself. It requires scalable and reproducible processes that protect these sensitive products while maintaining efficiency from process development through commercial production. At Repligen, we collaborate with biopharmaceutical manufacturers to help streamline complex mRNA workflows. Our integrated solutions for filtration, chromatography, fluid management, and process analytics solutions are designed to enhance process consistency, accelerate scale-up, and strengthen manufacturing confidence across the entire development and production lifecycle.
What Is mRNA?
Messenger RNA (mRNA) is a naturally occurring molecule that carries instructions for protein production within cells. In therapeutics and vaccines, synthetic mRNA is used to direct cells to produce a specific protein that drives a desired biological response.
For vaccines, mRNA enables cells to produce antigens that stimulate the immune system to recognize and respond to disease.
For therapeutics applications, mRNA enables the transient expression of proteins and other biologics, supporting a wide range of innovative treatment approaches, including:
- Cancer immunotherapies
- Protein replacement therapies
- Gene editing and gene modulation approaches
- Regenerative medicine & tissue repair
- Personalized and precision medicines
- Rare and genetic disease treatments
- In vivo cell engineering and cell therapies
- Immune modulation and autoimmune disease therapies
Because mRNA platforms can be designed and adapted quickly, they offer an efficient path for developing new therapies and responding to emerging health needs.
Common Challenges in mRNA Process Development
mRNA manufacturing introduces unique process development and purification challenges. The molecules are sensitive, the workflows are complex, and process consistency becomes increasingly important as manufacturing scales.
Teams developing mRNA therapies need to balance several priorities at once:
- Protecting product integrity
- Removing product and non-product related impurities
- Maintaining recovery and yield
- Scaling processes confidently
- Improving process visibility and control
Addressing these challenges early can help reduce process variability, improve manufacturability, and accelerate development timelines.
Maintaining mRNA Integrity
mRNA molecules are highly sensitive to degradation, shear exposure, enzymatic activity, and environmental conditions. Even small process inconsistencies can impact product quality and recovery.
Manufacturers need process technologies that support gentle handling while maintaining throughput and scalability.
Following in vitro transcription (IVT), manufacturers must efficiently remove process and product-related impurities including:
- Double-stranded RNA (dsRNA)
- Residual DNA templates
- Residual Enzymes and host-cell proteins
- Unincorporated nucleotides and reaction components
- RNA aggregates, truncated species, and fragments
Effective impurity removal is essential to ensure product quality, safety, potency, and regulatory compliance while supporting robust and scalable manufacturing processes.
Processes that perform well at laboratory scale can behave differently during process scale-up and commercial manufacturing. As production volumes increase, manufacturers encounter challenges such as:
- Membrane fouling and filter performance variability
- Flux variability and process inconsistencies
- Product loss and reduced recovery yields
- Mixing and fluid-handling inconsistencies
- Variability in LNP formation and encapsulation efficiency
Developing scalable, robust workflows early in the process helps reduce risk during scale-up, technology transfer, and commercial manufacturing while improving process consistency and manufacturing efficiency.
As mRNA manufacturing evolves toward more intensified, automated, and connected operations, real-time process monitoring and analytics are becoming increasingly important.Manufacturers are seeking solutions that enable them to:
- Reduce manual sampling and offline testing
- Accelerate data-driven decision-making
- Improve process consistency and reproducibility
- Support real-time monitor and process control strategies
- Enable more efficient scale-up and tech transfer
Enhanced process visibility helps manufacturing teams respond more quickly to process deviations, optimize performance, and operate with greater confidence.
mRNA Manufacturing Process
mRNA manufacturing integrates synthesis, purification, formulation, and final processing into a highly controlled and scalable workflow. Because mRNA is sensitive to enzymatic degradation, shear stress, and process variability, each manufacturing step plays a critical role in ensuring product quality, potency, safety, and reproducibility.
Typical mRNA Manufacturing Workflow
Each stage of the workflow contributes to overall process robustness, scalability, and product quality, making integrated process control and analytical monitoring increasingly important across mRNA manufacturing.
Each step plays an important role in overall process performance, product quality, and scalability.
Plasmid DNA (pDNA) Template Preparation
Production, amplification, linearization, and purification of plasmid DNA templates used for in vitro transcription (IVT). High-quality pDNA is essential for transcription efficiency and final product consistency.
In Vitro Transcription (IVT)
Enzymatic synthesis of mRNA using RNA polymerase, nucleotides, and the linearized DNA template. This step generates the target mRNA transcript and is a key determinant of yield and product quality.
Enzymatic Processing and mRNA Modification
Post-transcription processing steps such as 5’ capping, poly(A) tail optimization, and, in some workflows, enzymatic cleanup or nucleotide modification. These steps help improve mRNA stability, translation efficiency, and reduce innate immune activation.
Purification
Removal of process and product-related impurities, including dsRNA, proteins, residual DNA, templates, enzymes, proteins, endotoxins, free nucleotides, and truncated RNA species. Purification is critical for product safety, efficacy, and regulatory compliance.
Ultrafiltration and Diafiltration (UF/DF)
Concentration and buffer exchange operations are used to prepare purified mRNA for downstream formulation. UF/DF helps achieve target concentration, remove residual small molecules, and establish formulation-compatible buffer conditions.
Lipid Nanoparticle (LNP) Formulation
Encapsulation of mRNA into lipid nanoparticles using controlled mixing technologies. LNPs protect mRNA from degradation, support intracellular delivery, and strongly influence particle size, encapsulation efficiency, biodistribution, and overall therapeutic performance.
Sterile Filtration and Fill-Finish
Final sterile processing, filtration, aseptic filling and packaging steps performed prior to clinical or commercial distribution. These operations are essential for maintaining sterility, product integrity, and shelf stability.
Each step plays an important role in overall process performance, product quality, and scalability.
Lipid Nanoparticles (LNPs) in mRNA Therapeutics
Lipid nanoparticles are a critical part of mRNA delivery. Without protection, mRNA molecules degrade quickly in the body and are not efficiently delivered into cells. LNPs help protect the molecule and enable effective intracellular delivery.
Why LNPs Matter
Addressing these challenges early can help reduce process variability, improve manufacturability, and accelerate development timelines. Because of this, manufacturers often focus on improving control and reproducibility during formulation and mixing operations.
Repligen Solutions for mRNA Manufacturing
Repligen technologies are designed to help manufacturers improve process efficiency, maintain product quality, and scale manufacturing with greater confidence.
Tangential Flow Filtration for mRNA Purification
Tangential flow filtration (TFF) is widely used in mRNA workflows for:
- Concentration
- Diafiltration
- Buffer exchange
- Impurity removal
TFF plays an important role in preparing mRNA intermediates and final drug substance for downstream formulation and processing.
Careful optimization of membrane selection, flow conditions, transmembrane pressure (TMP), and process parameters is essential to maintain product integrity and process efficiency.
Common Challenges
Manufacturers often need to manage:
- Flux decline during extended processing
- Recovery loss and reduced recovery yields
- Membrane fouling and throughput limitations
- Product adsorption and nonspecific binding
- Process reproducibility and scale-up consistency
- Shear sensitivity of mRNA and LNP formulations
How Repligen Helps
Repligen solutions are designed to support:
- High product recovery and yield retention
- Gentle processing conditions for sensitive molecules
- Scalable process development and manufacturing workflows
- Improved process consistency and reproducibility
- Flexible platform development from R&D through commercial scale
- Integration with automated and intensified manufacturing strategies
Related Solutions
KrosFlo® Tangential Flow Filtration systems
KrosFlo® tangential flow filtration (TFF) systems by Repligen provide high-performance ultrafiltration/diafiltration (UF/DF) solutions across research, process development and GMP manufacturing. Engineered to streamline downstream processes, KrosFlo® TFF systems feature advanced automation capabilities, support most filter and membrane options, and can be integrated with advanced process analytics technologies.
TangenX® Flat Sheet Cassettes
KrosFlo® tangential flow filtration (TFF) systems by Repligen provide high-performance ultrafiltration/diafiltration (UF/DF) solutions across research, process development and GMP manufacturing. Engineered to streamline downstream processes, KrosFlo® TFF systems feature advanced automation capabilities, support most filter and membrane options, and can be integrated with advanced process analytics technologies.
Hollow Fiber Filters
Ideal for ultrafiltration and microfiltration of shear-sensitive modalities, Spectrum® Hollow Fiber Filters for TFF can accommodate the widest range of scales, membrane chemistries and pore sizes to maximize process outcomes.
Process Analytics and Real-Time Monitoring
As mRNA manufacturing processes become more integrated, automated, and data-driven, real-time analytics and process analytical technologies (PAT) are increasingly important for improving process understanding, consistency, and operational control.
Enhanced process monitoring can help reduce variability, improve manufacturing efficiency, and support more robust process development and commercial operations.
Common Challenges
Manufacturers often need better ways to:
- Support process consistency and reproducibility during scale-up
- Monitor concentration and critical process parameters in real time
- Reduce reliance on manual sampling and offline testing
- Improve process visibility across unit operations
- Enable faster, data-driven decision-making
- Advance toward real-time process control strategies
How Repligen Helps
Repligen PAT technology solutions are designed to support:
- Real-time monitoring and in-line measurement capabilities
- Improved process understanding and operational insight
- Faster process development and optimization
- More consistent manufacturing performance
- Reduced manual intervention and offline analysis
- Integration with automated and intensified bioprocess workflows
Related Solutions
PATsmart™ FlowVPX® System
Designed for GMP environments, the PATsmart™ FlowVPX® spectrophotometer delivers continuous, in-line concentration measurement during downstream processing, providing real-time data to actively control the process as it runs. This level of control is made possible by Variable Pathlength Technology (VPT), which enables accurate, dilution-free concentration measurement across development, scale-up, and GMP manufacturing.
PATsmart™ SoloVPE® PLUS System
UV-Vis Concentration Measurement for GMP and Non-GMP Testing The new PATsmart™ SoloVPE® PLUS System features patented variable pathlength technology (VPT), providing precise concentration measurements with no need for costly dilutions. This reliable solution delivers fast, accurate results with system-to-system, operator-to-operator, and site-to-site consistency, ensuring high-quality performance across various bioprocessing applications.
PATsmart™ FlowVPE® System
The PATsmart™ FlowVPE® System uses the power of Slope Spectroscopy for online process monitoring and PAT fields. Offering process insights and enabling innovation, the FlowVPE helps accelerate development, reduce risk, and increase process efficiency.
Chromatography Solutions for Impurity Removal
Purification strategies are critical for removing impurities while maintaining product integrity and process efficiency.
Repligen chromatography solutions help manufacturers build purification workflows.
Common Challenges
Manufacturers often need to manage:
- Improve dsRNA removal
- Increase purification efficiency
- Simplify scale-up
- Reduce process complexity
How Repligen Helps
Repligen solutions are designed to support:
- Scalable
- Reproducible
- Flexible
- Efficient to implement
OPUS® Pre-packed Chromatography Columns
Accelerate process development and scale-up with consistent performance, reduced operational complexity, and faster deployment from lab to commercial production.
Chromatography
Increase purification efficiency with systems, pre-packed columns, and resins engineered for modern biologics manufacturing.
Affinity Resins
Chromatography resins that deliver high binding capacity, and fast flow rates so biopharma teams purify antibodies, viral vectors, and new modalities with higher yield and better process economics.
Single-Use Fluid Management for Flexible Manufacturing
Single-use systems can help manufacturers improve flexibility while reducing operational complexity and contamination risk.Enhanced process monitoring can help reduce variability, improve manufacturing efficiency, and support more robust process development and commercial operations.
Common Challenges
Manufacturing teams are often focused on:
- Reducing turnaround time
- Simplifying changeovers
- Supporting multiproduct facilities
- Maintaining closed processing environments
How Repligen Helps
Repligen fluid management solutions are designed to support:
- Flexible manufacturing operations
- Faster deployment
- Simplified workflows
- Closed-system processing
ProConnex® Flow Paths
ProConnex® Flow Paths for TFF and Chromatography processes are single-use and engineered for optimum performance, reproducibility and time savings. System specific flow paths provide speed and reliability. Configured flow paths prioritize process requirements and sterility.
Single -Use Fluid Management
Move, mix, store, and transfer critical process fluids with single-use solutions designed for speed, sterility, and operational flexibility.
Fluid Management
Own your process with ProConnex® — streamlined fluid management solutions that reduces risk, improves consistency, and accelerates your path to production.
Supporting the Future of mRNA Manufacturing
As mRNA therapeutics continue to evolve, manufacturers are looking for process solutions that support:
Faster development timelines
Greater manufacturing flexibility
More consistent product quality
Scalable production strategies
Improved process control
Repligen works alongside biopharmaceutical manufacturers to help build manufacturing processes that are practical, scalable, and designed for long-term success.
mRNA manufacturing is the process of producing messenger RNA therapeutics or vaccines through synthesis, purification, formulation, and sterile processing operations.
LNPs protect mRNA molecules and help deliver them into cells efficiently, improving stability and therapeutic performance.
Common impurities include dsRNA, residual DNA, proteins, enzymes, free nucleotides, and aggregates.
TFF is commonly used for concentration, diafiltration, and buffer exchange while helping maintain product recovery and process scalability.
Repligen provides filtration, chromatography, fluid management, and process analytics technologies that help manufacturers improve process consistency, scalability, and operational confidence.
Explore mRNA Quantification and Analytical Strategies for Development, Manufacturing, and Quality Control
Developing and manufacturing mRNA therapeutics requires analytical methods that can accurately quantify mRNA, support process development, and enable efficient quality control. As mRNA modalities continue to evolve, analytical teams face increasing pressure to generate reliable data while reducing workflow complexity and accelerating decision-making.
This collection of technical resources explores practical approaches to mRNA quantification and characterization across development, manufacturing, and QC environments. Learn how variable pathlength spectroscopy and slope spectroscopy can support direct measurement of mRNA in lipid nanoparticle (LNP) formulations, streamline method validation and transfer, reduce sample preparation requirements, and improve analytical efficiency. You'll also discover emerging strategies for dsRNA removal and quantitation that can help address the challenges associated with next-generation mRNA therapeutics.